TcoF overview
TcoF: MED13L
GeneID: 1954
Name: Mediator of RNA polymerase II transcription subunit 13-like
Ensembl: ENSG00000123066
Species: Human
Class: class 3
Family: Mediator complex
Disease: 7
Go term: 3
Pathway: 2
Hallmark: --
Super Enhancer:

chr12:116736887-116743225 chr12:116736742-116764186 chr12:116452663-116510379 chr12:116672994-116741867 chr12:116548174-116559424 chr12:116694988-116713911 chr12:116678479-116738698 chr12:116703779-116719422 chr12:116609372-116653836 chr12:116483205-116528530 chr12:116566820-116585328 chr12:116673120-116715410 chr12:116673331-116721116 chr12:116703509-116719431 chr12:116667883-116715326 chr12:116673909-116721398 chr12:116701313-116724238 chr12:116673191-116742552 chr12:116669723-116742159 chr12:116431834-116513819 chr12:116394055-116442870 chr12:116818716-116828689 chr12:116818660-116827930 chr12:116783522-116849440 chr12:116786376-116824510 chr12:116814388-116828068 chr12:116813484-116830535 chr12:116796524-116824042 chr12:116796392-116830595 chr12:116775917-116823015 chr12:116813750-116830491 chr12:116813762-116835677 chr12:116796427-116829340 chr12:116783770-116827858 chr12:116820930-116845225 chr12:116813693-116829620 chr12:116813639-116829049 chr12:116821721-116845654 chr12:116795195-116820444 chr12:116792735-116823996 chr12:116796021-116845874 chr12:116813674-116830280 chr12:116813843-116829346 chr12:116796110-116835962 chr12:116796237-116849246 chr12:116819055-116845213 chr12:116796424-116821013 chr12:116813468-116845791 chr12:116786211-116845844 chr12:116796043-116823029 chr12:116818718-116827865 chr12:116815792-116820788 chr12:116796154-116828683 chr12:116795949-116829029 chr12:116795818-116824559 chr12:116795764-116829154 chr12:116796061-116824569

Enhancer:

chr12:117052300-117053520 chr12:116399200-116401210 chr12:116579380-116579860 chr12:116580180-116580510 chr12:116997240-116999570 chr12:116378710-116379520 chr12:116490980-116493230 chr12:116567860-116569870 chr12:116570430-116572060 chr12:116572880-116575150 chr12:116576000-116577540 chr12:116580570-116582780 chr12:116601570-116603770 chr12:116603840-116604020 chr12:116623820-116625220 chr12:116642230-116643620 chr12:116659950-116660930 chr12:116681360-116683260 chr12:116698030-116698240 chr12:116698640-116699280 chr12:116699360-116699760 chr12:116822180-116824050 chr12:117031580-117034070 chr12:117041450-117043930 chr12:117299270-117300600 chr12:117300920-117303340 chr12:117316350-117318780 chr12:117349160-117351130 chr12:117362050-117363610 chr12:117419780-117421630 chr12:117095710-117097100 chr12:116369930-116370950 chr12:116381040-116382280 chr12:116982040-116984460 chr12:117067270-117068000 chr12:117080240-117080740 chr12:116955150-116956040 chr12:116958020-116960040 chr12:116563870-116564800 chr12:116700420-116701050 chr12:116701220-116702000 chr12:116712450-116714860 chr12:116551360-116552670 chr12:116591620-116592470 chr12:116684110-116684800 chr12:116686660-116686830 chr12:116694830-116695550 chr12:117040920-117041430 chr12:116725580-116727670 chr12:116740320-116741180 chr12:116741680-116742150 chr12:116756440-116758780 chr12:116761230-116762240 chr12:116762350-116764540 chr12:116984870-116987260 chr12:117070720-117071820 chr12:116679070-116679700 chr12:116826920-116829150 chr12:116971420-116971770 chr12:116980240-116981070 chr12:117313660-117314490

Promoter:

chr12:116391677-116715524

 ChIP-seq based regulatory details of MED13L
Sample ID Experiment target Biosample type Biosample term name GSM ID Tissue type Source
 Downstream target genes of MED13L
 Protein-protein interaction of MED13L
OFFICIAL_SYMBOL_A OFFICIAL_SYMBOL_B EXPERIMENTAL_SYSTEM PUBMED_ID ORGANISM_A_ID ORGANISM_B_ID SOURCE
MED13L MED10 Co-fractionation 26344197 9606 9606 BIOGRID
MED13L MED16 Co-fractionation 26344197 9606 9606 BIOGRID
MED13L MED27 Co-fractionation 26344197 9606 9606 BIOGRID
MED13L MED6 Co-fractionation 26344197 9606 9606 BIOGRID
MED13L MED18 Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L MED22 Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L MED11 Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L MED6 Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L MED19 Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L MED28 Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L MED27 Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L MED26 Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L CCNC Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L CDK19 Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L CDK8 Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L MED12L Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L ACAD11 Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L ATAD3B Affinity Capture-MS 24981860 9606 9606 BIOGRID
MED13L RPAP2 Affinity Capture-MS 24981860 9606 9606 BIOGRID
 Annotation of MED13L
 TCGA cancer survival map of MED13L


Calculate the hazards ratio based on Cox PH Model.
Add the 95% CI as dotted line.
Reset Add The plot axis-x order will follow the list.


Calculate the hazards ratio based on Cox PH Model.
We use log2(TPM + 1) for log-scale.
All Add
Reset The plot is based on the datasets of list.


 Disease information of  MED13L